CD39: the potential target in small cell lung cancer

BACKGROUND: It has been proven that the treatment window of small cell lung cancer (SCLC) is short, so it is vital to find other possible therapeutic targets. CD39 inhibits natural killer (NK) cells and promotes the occurrence and metastasis of tumors. There has been little research about the role o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shanhao, Wu, Shengyu, Zhang, Liping, Zhang, Wei, Liu, Yu, Chen, Bin, Zhao, Sha, Li, Wei, Sun, Chenglong, Wang, Lei, Jia, Keyi, Wang, Hao, Chen, Peixin, Wu, Chunyan, Zhu, Junjie, He, Yayi, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481638/
https://www.ncbi.nlm.nih.gov/pubmed/32953520
http://dx.doi.org/10.21037/tlcr-20-798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481638/
https://www.ncbi.nlm.nih.gov/pubmed/32953520
http://dx.doi.org/10.21037/tlcr-20-798

Ejemplares similares